Vascular smooth muscle from a strain of genetically hypertensive rats is less reactive to specific (norepinephrine and serotonin) and nonspecific (KCl) smooth muscle contractile substances than is comparable tissue from normotensive animals. The mechanism responsible for this abnormality may be related to the intrinsic contractility of the muscle, since all of the agonists were affected to about the same degree. On the other hand, stimulation of beta adrenergic sites in aortas from both hypertensive and normotensive rats with isoproterenol produced the classical relaxation. Thus, hypertension in the SHR is not due to the absence of beta receptors in the vascular tree. Reduction of alpha receptor activity plus slight enhancement of beta activity may be a compensatory mechanism to reduce the elevated blood pressure. Other compensatory mechanisms may be operative in the SHR; for example, the biosynthesis and release of catecholamines are reduced (7). However, since the tissue response to a nonspecific stimulant, such as KCl, is depressed, it would seem that in the SHR the responsiveness of the muscle itself to contract is reduced rather than there being a specific modification of the alpha and beta receptors. Although histamine occurs in the brain of various species, its function in the central nervous system is unclear. In the brain, histamine is concentrated mainly in the gray matter, and has a regional and subcellular localization analogous to other neural amines having probable transmitter function (1). Data obtained from peripheral systems show that increased capacity to form histamine is correlated with periods of greatest mitotic activity in rapidly growing tissues (2). The possibility exists that histamine may be involved in growth processes in the central nervous system as well as in neurotransmission. We determined the histamine levels (total histamine, expressed per brain and per gram of brain) in developing rat brain and compared them to levels of other amines and to phases of cell growth and differentiation. Spermidine, which similarly increases in peripheral tissues during rapid growth (3), was also measured in developing rat brain.
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Sprague-Dawley rats (4) obtained at 10 days gestation were kept in individual cages where they gave birth and remained with their litters until the time of weaning. The rats were given free access to water and Purina laboratory chow. All animals were killed by decapitation. To provide a relatively constant sample weight, a varying number of brains were pooled depending on their size. The samples were immediately homogenized in cold O.4N perchloric acid; the homogenate was centrifuged and the supernatant adjusted to pH 7.5 with tris(hydroxymethyl)aminomethane. Histamine and spermidine were; adsorbed to Amberlite CG-50 (5). Columns were then washed with distilled water and eluted with IN HC1. Spermidine was determined by reaction with o-phthalaldehyde (6). Histamine was extracted from the eluate and assayed by a modification of the method of Anton and Sayre (7). The modification entailed the substitution of a potassium phosphate-perchloric acid wash (solution identical to initial extraction media) for the chloroform wash. All samples were read in an Aminco-Bow- Histamine concentration in fetal brain was higher at 17 days gestation (earliest time examined) than at any s Lbsequent time, but decreased sharply just before birth. Levels increased to maximum postnatal concentrations 5 to 1 0 days later and then steadily declined to low adult values by the time of weaning (Fig. 1A) . The large fluctuations in perinatal histamine concentration cannot be explained by the small changes in brain weight. The slow decline starting 27 days after conception might appear related to increasing brain weight; however, a similar decline occurs when values are expressed on a per brain basis (Fig. 1B) . Six days after birth the concentration of histamine was higher in cortex than in cerebellum or brain stem, but by adulthood this relation was reversed due to a larger decrease in histamineconcentration in'the cortex (Table 1) .
The developmental pattern for hi.tamine in the central nervous system. iS distinctly different from that for other monoamines.' Whereas dopamine (8), norepinephrine (9), and serotonin (10) content steadily increases in brain fromt late gestation to maturity, histamine content is highest during early development but declines to very low amounts 3 weeks after birth. Similarly, while histamine decreases fivefold at partturition, Tissue concentrations reflect a balance between synthesis, uptake, binding, and catabolism,. Since the major pathway of histamine catabolism is by oxidative deamination (14), the absence of histaminase in the fetus (15) may contribute to the high concentration of histamine in fetal brain. Histamine . is formed by the decarboxylation of histidine. We analyzed brain for histidine decarboxylase (16) in rats at 17 days gestation and in, adult rats. Fetal liver and adult stomach were also examined. Whereas high activity was found in liver and stomach, no detectable activity was observed in fetal or adult brain. Therefore, the histamine measured in brain may enter from peripheral sites of synthesis. Moreover, the brain during fetal and neonatal development exhibits altered permeability for many substances (11). Our studies in neonatal rats show that C14-histamine penetrates readily into brain after subcutaneous administration. After 30 minutes the concentration in the brain is 10) to 30 percent of that in the blood. Thus, higher concentrations oft histamine in fetal 'brain may reflect increased peripheral histamine fiormation which appears to occur during early development (17). However, the potent histaminolytic activity in the placenta 
